Factors associated with the informal use of HIV pre-exposure prophylaxis in Germany: a cross-sectional study.

ABSTRACT: INTRODUCTION:Until September 2019, pre-exposure prophylaxis (PrEP) with tenofovir disoproxil/emtricitabine for HIV prevention was not covered by health insurance plans in Germany, and was only available through private prescriptions with self-pay or through informal non-prescription sources. The objective of this study was to investigate the proportion of informal PrEP use among PrEP users and to identify factors of public health relevance that might be associated with informal PrEP use. METHODS:We conducted a cross-sectional study recruiting PrEP users independent of their PrEP source. Clients from anonymous community testing checkpoints, users of three dating apps for men who have sex with men residing in Germany and users of a PrEP community website, were recruited to complete a short a

SUBMITTER: Koppe U 

PROVIDER: S-EPMC6776824 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature